Briefs: New Cambridge Uni Centre for Obesity; Autonomy snags Integrated Media Mgt as client for Cardiff

A new centre on the Cambridge Biomedical Campus next to Addenbrooke's Hospital has been set up to address the threat to public health posed by obesity, diabetes and related diseases.

The University of Cambridge, the Medical Research Council and Cambridge University Hospitals NHS Foundation Trust have joined forces to create the Institute of Metabolic Science.

Led by co-directors Professors Steve O'Rahily and Nick Wareham, the IMS said it aspires to become a world-leading centre focused on understanding the biological basis of diabetes, obesity, and related disorders and translating those scientific discoveries into improved patient care and disease prevention.

A major aim of the institute is to encourage daily interaction between basic and clinical scientists, epidemiologists and clinicians to maximise the impact of research into the prevention and treatment of these diseases and to improve the quality of patient care.

Housed in a new £15m facility on the Cambridge Biomedical Campus, the IMS brings together the Metabolic Research Laboratories of the University of Cambridge, the MRC Epidemiology Unit, The Wolfson Diabetes and Endocrine Clinic and the Weston Centre for Childhood and Adolescent Diabetes and Endocrinology.

# # # #

Autonomy Corporation plc, a global leader in infrastructure software for the enterprise, said that Integrated Media Management, a leading document output management and automation technology provider, has integrated Cardiff's intuitive eForm designer platform as the de facto standard for its document preparation and electronic signature capture solution, TotaleAtlas, helping to electronically streamline historically paper-based document processes for more than 600 financial institutions. IMM has been a long-standing OEM customer of Autonomy for more than six years.

Cardiff's LiquidOffice eForm Designer is a drag and drop application that provides an intuitive, easy to use interface for novice form designers, while offering powerful tools, such as "snap-to" guides and point-and-click database lookups, for more advanced form designers. It also supports distributed form design to provide end-users with the ability to easily create and publish rich online forms and comes with a wide selection of sample forms and a Gallery of pre-made form and field templates. Custom form elements can be created and saved into the Gallery, facilitating corporate standards for forms creation and design.

 



Previous articles
Private investment in stem cell research stalled; patent applications in China soar: Marks & Clerk
Autonomy says Q3 revenue will be better than expected, profits to be strong
Market welcomes ARM's strong half year performance
Acambis’ shares gain on US’ FDA approval of its smallpox vaccine
ARM reports small growth in 1H08 revenue, slip in pretax profit in tough market conditions; market warms to outlook
Prelude Trust adds 3 firms to portfolio; sees net asset value slip £0.9m
Autonomy reports record Q1 but reticence on the future causes disquiet in the stock market
Acambis’ new CEO to get feet under the table in time for financial results: FDA to review its smallpox vaccine
Acambis lodges opposition to MVA patent; closes in on US Govt smallpox vaccine contract
Intercytex beefs up management; reports progress on cell therapy product pipeline
Subscribe

 

Corporate profiles

 • Cambridge Semiconductor


David Baillie
Chief Executive Officer


Cambridge Semiconductor Ltd was founded in August 2000 as a venture-backed technology spin out from the High-Voltage Microelectronics Group at Cambridge University. CamSemi’s (as it likes to call itself) unique and patented PowerBrane technology uses standard manufacturing processes to integrate multiple,

[Cambridge Semiconductor's profile]


Top20 Index




Currently: 80.53